LAURA ALEXANDER: Open Payments
NPI 1255987335 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 55 payments from 24 companies in 2025. Trend: 2023 $130 · 2024 $147 · 2025 $966
Food & beverage: $966
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $152 |
| Otsuka America Pharmaceutical, Inc. | 7 | $135 |
| Axsome Therapeutics, Inc. | 6 | $105 |
| ABBVIE INC. | 5 | $92 |
| Corcept Therapeutics | 4 | $76 |
| Corium, LLC | 3 | $41 |
| Novo Nordisk Inc | 2 | $37 |
| Biogen, Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
Products named: REXULTI, CAPLYTA, Auvelity, Korlym, VRAYLAR, Azstarys, Ozempic, ZURZUVAE.
Industry payments across IN — which companies pay providers there.
